Andere Sprachen Navamedic ASA

Aktien

Realtime Oslo Bors Andere Börsenplätze 15:12:17 08.05.2024			% 5 Tage	% 1. Jan.
33.2 ^NOK	-0.90%		-1.19%	-9.54%

06.05.	Navamedic führt Medikament zur Behandlung von Erektionsstörungen in Schweden ein	MT
30.04.	Navamedic ASA meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Navamedic Rolls Out Erectile Dysfunction Drug in Sweden	06.05.
Navamedic ASA: Broad launch for Eroxon® in Sweden today	06.05.
Navamedic ASA: Annual Report 2023	30.04.
Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	30.04.
Navamedic Q1 2024: Successful product launch and steady operational progress	30.04.
Navamedic ASA: Invitation to 2024 1st quarter presentation	23.04.
Disclosure in NAVAMEDIC ASA	21.03.
Major shareholder disclosure in Navamedic ASA	18.03.
Navamedic ASA - Mandatory notification of trade by primary insider	15.03.
Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options	15.03.
Navamedic welcomes new shareholders	13.03.
Navamedic ASA - Notification of Major Holdings	13.03.
Ingerø Reiten Investment Divests Navamedic Stake in NOK95 Million Deal	13.03.
Navamedic ASA: Notification of major shareholding and mandatory notification of trade	12.03.
Contemplated block sale of existing shares in Navamedic ASA	12.03.
An unknown buyer acquired unknown minority stake in Navamedic ASA (OB:NAVA) from Ingerø Reiten Investment Company As for NOK 95 million.	12.03.
Navamedic ASA: Mandatory notification of trade	22.02.
Navamedic ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	15.02.
Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives	15.02.
Navamedic ASA: Invitation to 2023 4th quarter presentation	13.02.

Keine Ergebnisse zu dieser Suche